WO1999000110A1 - Use of tannins cross-linked in the presence of proteins non-cross-linked with the tannins - Google Patents

Use of tannins cross-linked in the presence of proteins non-cross-linked with the tannins Download PDF

Info

Publication number
WO1999000110A1
WO1999000110A1 PCT/FR1998/001364 FR9801364W WO9900110A1 WO 1999000110 A1 WO1999000110 A1 WO 1999000110A1 FR 9801364 W FR9801364 W FR 9801364W WO 9900110 A1 WO9900110 A1 WO 9900110A1
Authority
WO
WIPO (PCT)
Prior art keywords
tannins
crosslinked
protein
proteins
skin
Prior art date
Application number
PCT/FR1998/001364
Other languages
French (fr)
Inventor
Patrice Andre
Isabelle Renimel
Original Assignee
Parfums Christian Dior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parfums Christian Dior filed Critical Parfums Christian Dior
Publication of WO1999000110A1 publication Critical patent/WO1999000110A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11Encapsulated compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/412Microsized, i.e. having sizes between 0.1 and 100 microns
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Definitions

  • the invention essentially relates to the use of crosslinked tannins in the presence of proteins which are not crosslinked with the tannins as a cosmetic agent for improving the smoothing of the skin, for an astringent or firming effect.
  • tannins are very old in cosmetics. When applied externally, the tannins react with the skin and mucous membranes and cause waterproofing of the most superficial layers. Tannins are also used in cosmetics for their "firming" effects linked to their astringent properties.
  • the use of tannins in cosmetics is limited due to their instability in the usual cosmetic media such as gels, creams, emulsions and lotions. In particular, they produce, by degradation, colored derivatives providing an unacceptable brownish appearance.
  • Tannins are also known to also have the property of precipitating proteins, in particular gelatin.
  • a general method of measuring serum albumin consists of precipitating it by the tannins.
  • the tannins combine with proteins, and other macromolecules, thanks to hydrogen bonds between the phenolic functions of the tannins and certain functions of the proteins.
  • tannins has been made in practice impossible in cosmetics in the presence of proteins in the same product due to the tannin-protein reactivity.
  • microcapsules with a wall of flavonoids crosslinked by interfacial crosslinking are described.
  • the crosslinking of the flavonoids makes it possible to stabilize them and prevent any changes in color over time.
  • the initial specific activity of the flavonoids is maintained (see the aims of the invention page 2, line 9 to page 3, line 24).
  • crosslinked tannins combined with proteins not crosslinked with tannins, make it possible to considerably potentiate the smoothing effect of the skin, as well as to obtain a astringent effect, of a cosmetic composition containing them, and applied topically to the skin.
  • the present invention aims to solve the new technical problem consisting in the supply of a solution making it possible to find a new cosmetic formulation making it possible to improve the smoothing effect of the skin, and / or obtaining an astringent effect on the skin preferably during topical application
  • the present invention relates to the use of crosslinked tannins in the presence of protein not crosslinked with the tannins as a cosmetic agent for smoothing the skin, and / or for obtaining an astringent or firming effect.
  • the protein is added to a solution containing the crosslinked tannins previously prepared.
  • the crosslinked tannins are obtained by interfacial crosslinking, in particular in the form of a microcapsule or microparticle and the abovementioned proteins are present in a solution, in particular aqueous, containing the crosslinked tannins previously prepared.
  • the concentration of. anin is between 0.001% and 5%, preferably between 0.01% and 5%, and even better between 0.1% and 1%, by weight relative to the total weight of the final composition
  • the concentration of protein is between 0.01% and 10%, preferably between 0.1% and 10%, and even better between 1% and 5% by weight relative to the total weight of the final composition
  • the above-mentioned tannin is a water-soluble phenolic molecule having a molecular weight of between 500 and 3,000 daltons, in particular consisting of ohgomers procyanidolic, abbreviated as OPC in the pure state, or in the form of a mixture in the form of an extract from a natural source, for example grape seed proanthocyanidins.
  • tannins mention may be made of proanthocyanidols, procyanidins, picnogenols, hydrolysable tannins and in particular esters of glucose and of phenolic acids such as gallic acid and ellagic acid, and for example, officinal tannin is obtained from the gall of the oak (quercus infectoria).
  • Mention may also be made of green tea extracts containing epigallocatechin, gallate and other derivatives, or extracts with complex flavonoids.
  • the aforementioned protein is a protein compatible with a cosmetic or pharmaceutical application, in particular a protein of animal, human or vegetable origin such as an albumin such as serum albumin, ovalbumin, ⁇ -lactalbumin, globulins, fibrinogen, casein, collagen, atelocollagen, gelatin, gelatin hydrolysates, peptones, hemoglobin, vegetable proteins such as soy proteins, non-glytelins degraded or degraded, solubilized scleroproteins, proteins from milk in all its forms, soy flour.
  • an albumin such as serum albumin, ovalbumin, ⁇ -lactalbumin, globulins, fibrinogen, casein, collagen, atelocollagen, gelatin, gelatin hydrolysates, peptones, hemoglobin, vegetable proteins such as soy proteins, non-glytelins degraded or degraded, solubilized scleroproteins, proteins from milk in all its forms, soy flour.
  • the present invention also covers a process for the manufacture of a composition which is stable over time and contains tannins, in particular procyanidolic or OPC oligomers, in the presence of a protein, characterized in that one carries out in a first step the crosslinking of the tannins, in the absence of said protein, and in a second step, the crosslinked tannins are mixed with said protein.
  • a reaction medium containing the crosslinked tannins as such into which said protein is added, or else to separate the crosslinked tannins and to introduce them into a solution containing the protein, in particular to an aqueous solution.
  • the crosslinking of the tannins takes place by interfacial crosslinking, and in the currently preferred case where the tannins are water-soluble, the interfacial crosslinking is carried out on an emulsion in which the dispersed phase is an aqueous phase containing the tannins in solubilized form, by an interfacial crosslinking agent present in a continuous hydrophobic phase.
  • This interfacial crosslinking technique is advantageously that described in document FR-A-2 715 582 which is incorporated here by reference, in particular from page 6, line 30 to page 10, line 22, as well as manufacturing examples 1 to 25.
  • the crosslinking agent comprises a diacid chloride, preferably chosen from the group consisting of an aliphatic or aromatic diacid chloride, such as sebacoyl chloride, succinyl chloride, apipoyl chloride, terephthaloyl chloride, glutaryl chloride.
  • concentration of diacid chloride will preferably be between 0.2% and 10% by weight of the total weight of the reaction medium.
  • liquid substances used to constitute the hydrophobic phase it is possible to use liquid substances well known to those skilled in the art such as those mentioned on page 8, lines 7 to 14, and in particular fatty acid esters such as isopropyl myristate or ethyl oleate, mixtures of fatty acid esters commercially available such as for example the product Dragoxat ®, sold by the company Dragoco, vegetable oils, such as liquid olive, sweet almond oil, peanut oil, mineral oils, such as paraffin oil and any mixture of these liquid and hydrophobic substances. It is understandable that vegetable oils are particularly interesting since they are compatible with a cosmetic or pharmaceutical application.
  • the crosslinked tannins can advantageously be in the form of microcapsules or microparticles during crosslinking by interfacial crosslinking. These microcapsules or microparticles generally have a diameter lying in the range between 0.1 ⁇ m and 3 mm.
  • the first step of the process of the invention consists in carrying out beforehand the crosslinking of the tannins, in the absence of proteins, and can be carried out in accordance with Example 1 of FR-A-2 715 582.
  • Example 5 During the crosslinking of tannins constituted by procyanidolic oligomers of grape seeds, abbreviated OPC PR, the conditions of Example 5 can be used, which are combined with the protocol described in Example 1 of FR-A-2 715 582.
  • the present invention also covers a method of cosmetic treatment of the skin, to improve the smoothing of the skin, to obtain an astringent effect on the skin, in particular a firming effect, characterized in that it comprises the application to the affected areas of the skin of an effective amount of crosslinked tannins in combination with proteins not crosslinked with the tannins
  • composition comprising crosslinked tannins in the form of crosslinked grape seed proanthocvanidines, combined with a protein obtained from wheat, commercially available under the name of Tensine® from the company Silab® France
  • an aqueous phase is first prepared by dissolving 300 mg of a solution of procyanidolic oligomers of grape seeds, commercial references OPC PR, marketed by the company Sarpap, France, in 3 ml of a buffer. carbonate PH 11, or approximately 10% OPC.
  • the microcapsules prepared in step a) are separated from the aqueous suspension containing them by cent ⁇ fugation.
  • washings are carried out to eliminate the reaction medium.
  • the microcapsules thus washed can be mixed with an aqueous solution containing wheat protein.
  • compositions comprising various concentrations of crosslinked tannins, and proteins, as is well understood by those skilled in the art.
  • a test without OPC determines the quantity of albumin serum actually present in the supernatant and also defines the 100% of non-precipitated albumin serum.
  • the assay technique used is the Coomasie blue method with a reading of the optical density respectively at a wavelength of 590 nanometers and a wavelength of 465 nanometers to measure the absorbance called respectively Abs 59 o at 590 nanometers and Abs 465 at 465 nanometers.
  • the Abs 5 o / Abs 65 ratio makes it possible to determine the protein concentration as is easily understood by those skilled in the art.
  • the precipitation curve for bovine serum albumin or BSA shown in FIG. 1 is thus obtained, which represents the tannin concentration of 0 to 1 ng / ml on the abscissa and the% in soluble bovine serum albumin (BSA) on the ordinate.
  • Curve 1 is the control curve without tannin
  • curve 2 is the curve obtained with crosslinked tannins, here crosslinked OPCs
  • curve 3 is the curve obtained with free tannins, here free or uncrosslinked OPCs.
  • FIG. 2 represents on the abscissa the concentration in% of OPC which varies from 0 to 0.25%, as a function of the relative viscosity on the ordinate for a constant concentration of type 1 collagen of 0 0.05% in water at 29 ° C.
  • Curve 1 is obtained with the control collagen solution
  • curve 2 is obtained by adding an increasing concentration of free OPC
  • curve 3 is obtained by adding to the collagen solution an increasing concentration of crosslinked OPCs, obtained according to example).
  • OPC microcapsules are used as obtained in example la. These OPC microcapsules are formed following the establishment of ester bonds. The membrane that forms is therefore made up of esterified flavonoids. It is demonstrated by the present test that under the action of esterase, there is release over time of procyanidol monomers. The present test consists in bringing together 286 esterase units, constituted by an E 3019 esterase from the porcine pancreas commercially available from Sigma, with crosslinked OPCs according to example la, and after centrifugation at different times. (30 min; 1 hour; 2 hours; 3 hours; 4 hours and 6 hours), the composition of the supernatant is visualized by HPLC chromatography.
  • esterases are secreted from Ocland bodies in the stratum granulosum which will migrate to the surface of the stratum corneum.
  • the presence of esterases in the surface layer of the skin will allow an attack on the crosslinked OPC microcapsules and thus release the procyanidic oligomers endowed with tanning properties and which will crosslink the collagen present in the surface layer of the skin. and thus provide the smoothing effect of the skin demonstrated by the present invention, which is confirmed by the smoothing tests below.
  • Example 1 Each person received on different skin areas of one of the forearms, 4 different compositions according to the invention, as prepared in Example 1. On a skin area of the other forearm, they receive a control composition consisting solely of the excipient of said compositions of Example 1.
  • the + indication signifies an insignificant skin smoothing effect
  • the indication ++ means a slight smoothing of the skin
  • the indication +++ means a marked reduction in wrinkles and a fairly satisfactory smoothing of the skin
  • the indication ++++ signifies a very marked reduction in the depth of wrinkles and a very satisfactory smoothing of the skin.
  • the concentrations of protein (tensin) and of tannins, namely of proanthocyanidolic oligomers of crosslinked grape seeds (crosslinked OPC PR ) are expressed as a percentage by weight, relative to the total weight of the final composition. .
  • composition called "radiance boost” to smooth facial skin
  • composition is prepared from the following ingredients: - crosslinked OPC microcapsules, according to example 1 g,
  • this composition the 5 g of tensin are dissolved in approximately 40 g of distilled water, cold with mechanical stirring, then 1 g of the crosslinked OPC microcapsules prepared according to Example 1a is dispersed. While maintaining stirring, make up to 50 g with an aqueous excipient containing the perfume and the preservatives. Then added 50 g of a 0.1% Carbopol 940 gel neutralized with sodium hydroxide prepared separately.
  • a composition is thus obtained in the form of a gel which, applied to the skin of the face, produces in a few minutes a tightening effect which smoothes the skin by reducing wrinkles and fine lines.

Abstract

The invention concerns the use of tannins cross-linked in the presence of proteins non-cross-linked with the tannins as cosmetic agents to improve skin smoothing and/or to obtain an astringent effect. The invention also concerns a method for making a composition stable in time containing tannins in the presence of a protein, characterised in that in a first step, the tannins are cross-linked in the absence of said protein and in a second step the cross-linked tannins are mixed with said protein. The invention provides a method for the cosmetic treatment of the skin or for improving skin smoothing and/or for producing an astringent effect on the skin, in particular a toning effect.

Description

UTILISAΗON DE TANINS RETICULES EN PRESENCE DE PROTEINES NON RETICULEES AVEC LES TANINSUSE OF CROSSLINKED TANNINS IN THE PRESENCE OF PROTEINS NOT CROSSLINKED WITH TANNINS
L'invention concerne essentiellement l'utilisation de tanins réticulés en présence de protéines non réticulées avec les tanins comme agent cosmétique pour améliorer le lissage de la peau, pour un effet astringent, ou raffermissant.The invention essentially relates to the use of crosslinked tannins in the presence of proteins which are not crosslinked with the tannins as a cosmetic agent for improving the smoothing of the skin, for an astringent or firming effect.
L'utilisation de tanins est très ancienne en cosmétique. En application externe, les tanins réagissent avec la peau et les muqueuses et provoquent une imperméabilisation des couches les plus superficielles. Les tanins sont également utilisés en cosmétique pour leurs effets "raffermissant" liés à leurs propriétés astringentes. L'utilisation des tanins en cosmétique est limitée en raison de leur instabilité dans les milieux cosmétiques habituels tels que gels, crèmes, émulsions et lotions. En particulier, ils produisent par dégradation des dérivés colorés apportant un aspect brunâtre inacceptable.The use of tannins is very old in cosmetics. When applied externally, the tannins react with the skin and mucous membranes and cause waterproofing of the most superficial layers. Tannins are also used in cosmetics for their "firming" effects linked to their astringent properties. The use of tannins in cosmetics is limited due to their instability in the usual cosmetic media such as gels, creams, emulsions and lotions. In particular, they produce, by degradation, colored derivatives providing an unacceptable brownish appearance.
Les tanins sont également connus comme ayant aussi la propriété de précipiter les protéines, en particulier la gélatine.Tannins are also known to also have the property of precipitating proteins, in particular gelatin.
Ainsi, une méthode générale de dosage de la sérum albumine consiste à la précipiter par les tanins. Les tanins se combinent avec les protéines, et d'autres macromolécules, grâce à des liaisons hydrogènes entre les fonctions phénoliques des tanins et certaines fonctions des protéines.Thus, a general method of measuring serum albumin consists of precipitating it by the tannins. The tannins combine with proteins, and other macromolecules, thanks to hydrogen bonds between the phenolic functions of the tannins and certain functions of the proteins.
Dans ces circonstances, l'utilisation des tanins a été rendue en pratique impossible en cosmétique en présence de protéines dans le même produit du fait de la réactivité tanin-protéine.Under these circumstances, the use of tannins has been made in practice impossible in cosmetics in the presence of proteins in the same product due to the tannin-protein reactivity.
Dans la demande de brevet FR-A-2 715 582 du- CNRS, il est décrit des microcapsules à paroi de flavonoïdes réticulés par réticulation interfaciale. La réticulation des flavonoïdes permet de les stabiliser et de prévenir toutes les modifications de coloration au cours du temps. En outre, l'activité initiale spécifique des flavonoïdes est maintenue (voir les buts de l'invention page 2, ligne 9 à page 3, ligne 24).In patent application FR-A-2 715 582 of the CNRS, microcapsules with a wall of flavonoids crosslinked by interfacial crosslinking are described. The crosslinking of the flavonoids makes it possible to stabilize them and prevent any changes in color over time. In addition, the initial specific activity of the flavonoids is maintained (see the aims of the invention page 2, line 9 to page 3, line 24).
L'addition de protéines, présente initialement, est prévue dans un mode de réalisation particulier de sorte que la protéine est coréticulée avec le flavonoïde (page 4, ligne 11 à 15, et les exemples 3, 4, 6, 8, 10, 11, 13, 14, 16, 25 ainsi que les revendications 2 et 3 notamment).The addition of proteins, initially present, is provided in a particular embodiment so that the protein is co-crosslinked with the flavonoid (page 4, line 11 to 15, and examples 3, 4, 6, 8, 10, 11, 13, 14, 16, 25 as well as claims 2 and 3 in particular).
Dans le cadre de la présente invention, il vient d'être découvert de manière inattendue que les tanins réticulés, combinés à des protéines non réticulées avec les tanins, permettaient de potentialiser considérablement l'effet de lissage de la peau, ainsi que pour obtenir un effet astringent, d'une composition cosmétique les contenant, et appliques topiquement sur la peau.In the context of the present invention, it has just been unexpectedly discovered that crosslinked tannins, combined with proteins not crosslinked with tannins, make it possible to considerably potentiate the smoothing effect of the skin, as well as to obtain a astringent effect, of a cosmetic composition containing them, and applied topically to the skin.
Ainsi, selon un premier aspect, la présente invention a pour but de résoudre le nouveau problème technique consistant en la fourniture d'une solution permettant de trouver une nouvelle formulation cosmétique permettant d'améliorer l'effet de lissage de la peau, et/ou l'obtention d'un effet astringent sur la peau de préférence lors d'une application topiqueThus, according to a first aspect, the present invention aims to solve the new technical problem consisting in the supply of a solution making it possible to find a new cosmetic formulation making it possible to improve the smoothing effect of the skin, and / or obtaining an astringent effect on the skin preferably during topical application
Ce nouveau problème technique est résolu par la présente invention d'une manière, sûre et fiable, utilisable à l'échelle industrielle. Ainsi, selon un premier aspect, la présente invention concerne l'utilisation de tanins réticulés en présence de protéine non réticulées avec les tanins comme agent cosmétique pour le lissage de la peau, et/ou pour l'obtention d'un effet astringent ou raffermissantThis new technical problem is solved by the present invention in a manner, safe and reliable, usable on an industrial scale. Thus, according to a first aspect, the present invention relates to the use of crosslinked tannins in the presence of protein not crosslinked with the tannins as a cosmetic agent for smoothing the skin, and / or for obtaining an astringent or firming effect.
Selon une vaπante de réalisation particulière, la protéine est ajoutée à une solution contenant les tanins réticulés préalablement préparés.According to a particular embodiment, the protein is added to a solution containing the crosslinked tannins previously prepared.
Selon un mode de réalisation actuellement préféré, les tanins réticulés sont obtenus par réticulation interfaciale, en particulier sous forme de microcapsule ou microparticule et les protéines précitées sont présentes dans une solution, en particulier aqueuse, contenant les tanins réticulés préalablement préparés.According to a currently preferred embodiment, the crosslinked tannins are obtained by interfacial crosslinking, in particular in the form of a microcapsule or microparticle and the abovementioned proteins are present in a solution, in particular aqueous, containing the crosslinked tannins previously prepared.
Dans le cadre de l'invention, la concentration en. anin est comprise entre 0,001 % et 5 %, de préférence entre 0,01 % et 5 %, et encore mieux entre 0,1 % et 1 %, en poids par rapport au poids total de la composition finale, tandis que la concentration en protéine est comprise entre 0,01 % et 10 %, de préférence entre 0,1 % et 10 %, et encore mieux entre 1 % et 5 % en poids par rapport au poids total de la composition finaleIn the context of the invention, the concentration of. anin is between 0.001% and 5%, preferably between 0.01% and 5%, and even better between 0.1% and 1%, by weight relative to the total weight of the final composition, while the concentration of protein is between 0.01% and 10%, preferably between 0.1% and 10%, and even better between 1% and 5% by weight relative to the total weight of the final composition
Selon un mode de réalisation avantageux de l'invention, le tanin précité est une molécule phénohque hydrosoluble ayant un poids moléculaire compris entre 500 et 3 000 daltons, en particulier constitué par des ohgomères procyanidoliques, en abrégé dénommé OPC à l'état pur, ou à l'état de mélange sous forme d'extrait de source naturelle, par exemple des proanthocyanidines de pépins de raisin. Comme autres tanins, on peut citer les proanthocyanidols, les procyanidines, les picnogénols, les tanins hydrolysables et notamment des esters de glucose et d'acides phénoliques tels que l'acide gallique et l'acide ellagique, et par exemple, le tanin officinal est obtenu à partir de la galle du chêne (quercus infectoria).According to an advantageous embodiment of the invention, the above-mentioned tannin is a water-soluble phenolic molecule having a molecular weight of between 500 and 3,000 daltons, in particular consisting of ohgomers procyanidolic, abbreviated as OPC in the pure state, or in the form of a mixture in the form of an extract from a natural source, for example grape seed proanthocyanidins. As other tannins, mention may be made of proanthocyanidols, procyanidins, picnogenols, hydrolysable tannins and in particular esters of glucose and of phenolic acids such as gallic acid and ellagic acid, and for example, officinal tannin is obtained from the gall of the oak (quercus infectoria).
On peut également citer les extraits de thé vert contenant de l'épigallocatéchine, gallate et d'autres dérivés, ou des extraits à flavonoïdes complexes.Mention may also be made of green tea extracts containing epigallocatechin, gallate and other derivatives, or extracts with complex flavonoids.
Dans le cadre de l'invention, la protéine précitée est une protéine compatible avec une application cosmétique ou pharmaceutique, en particulier une protéine d'origine animale, humaine ou végétale telle qu'une albumine comme la sérum albumine, l'ovalbumine, l'α-lactalbumine, les globulines, le fibrinogène, la caséine, le collagène, l'atélocollagène, la gélatine, les hydrolysats de gélatine, les peptones, l'hémoglobine, les protéines végétales telles que les protéines du soja, des glytélines sous forme non dégradée ou dégradée, des scléroprotéines solubilisées, des protéines issues du lait sous toutes ses formes, la farine de soja.In the context of the invention, the aforementioned protein is a protein compatible with a cosmetic or pharmaceutical application, in particular a protein of animal, human or vegetable origin such as an albumin such as serum albumin, ovalbumin, α-lactalbumin, globulins, fibrinogen, casein, collagen, atelocollagen, gelatin, gelatin hydrolysates, peptones, hemoglobin, vegetable proteins such as soy proteins, non-glytelins degraded or degraded, solubilized scleroproteins, proteins from milk in all its forms, soy flour.
Selon un troisième aspect, la présente invention couvre également un procédé de fabrication d'une composition stable dans le temps contenant des tanins en particulier des oligomères procyanidoliques ou OPC, en présence d'une protéine, caractérisé en ce que l'on réalise dans une première étape la réticulation des tanins, en l'absence de ladite protéine, et dans une deuxième étape, on mélange les tanins réticulés avec ladite protéine. Pour réaliser ce mélange, on peut soit utiliser le milieu reactionnel contenant les tanins réticulés tels quels dans lequel on ajoute ladite protéine, soit encore séparer les tanins réticulés et les introduire dans une solution contenant la protéine, en particulier à une solution aqueuse.According to a third aspect, the present invention also covers a process for the manufacture of a composition which is stable over time and contains tannins, in particular procyanidolic or OPC oligomers, in the presence of a protein, characterized in that one carries out in a first step the crosslinking of the tannins, in the absence of said protein, and in a second step, the crosslinked tannins are mixed with said protein. To achieve this mixture, it is possible either to use the reaction medium containing the crosslinked tannins as such into which said protein is added, or else to separate the crosslinked tannins and to introduce them into a solution containing the protein, in particular to an aqueous solution.
Selon un mode de réalisation avantageux de l'invention, la réticulation des tanins a lieu par réticulation interfaciale, et dans le cas actuellement préféré où les tanins sont hydrosolubles, la réticulation interfaciale est réalisée sur une émulsion dans laquelle la phase dispersée est une phase aqueuse contenant les tanins sous forme solubilisée, par un agent de réticulation interfaciale présent dans une phase hydrophobe continue. Cette technique de réticulation interfaciale est avantageusement celle décrite dans le document FR-A-2 715 582 qui est incorporé ici par référence, en particulier de la page 6, ligne 30 à la page 10, ligne 22, ainsi que les exemples de fabrication 1 à 25. On observera en particulier que l'agent réticulant comprend un chlorure de diacide, de préférence choisi parmi le groupe consistant d'un chlorure de diacide aliphatique ou aromatique, tel que le chlorure de sébacoyle, le chlorure de succinyle, le chlorure d'apipoyle, le chlorure de téréphtaloyle, le chlorure de glutaryle. La concentration en chlorure de diacide sera de préférence comprise entre 0,2 % et 10 % en poids du poids total du milieu reactionnel. Comme substances utilisées pour constituer la phase hydrophobe, on pourra utiliser des substances liquides bien connues de l'homme de l'art telles que celles citées à la page 8, lignes 7 à 14, et en particulier des esters d'acide gras tels que le myristate d'isopropyle ou l'oléate d'éthyle, des mélanges d'esters d'acide gras disponibles dans le commerce tels que par exemple le produit Dragoxat®, commercialisé par la firme Dragoco, des huiles végétales, telles que l'huile d'olive, l'huile d'amande douce, l'huile d'arachide, les huiles minérales, telles qu'une huile de paraffine et tout mélange de ces substances liquides et hydrophobes. Il est bien compréhensible que les huiles végétales sont particulièrement intéressantes puisqu'elles sont compatibles avec une application cosmétique ou pharmaceutique. 11 est également possible d'utiliser des agents tensioactifs pour faciliter la préparation de l'émulsion comme décrit en page 8, lignes 15 à 22 de FR-A-2 715 582 où l'homme de l'art pourra se reporter. Ainsi, les tanins réticulés peuvent se présenter avantageusement sous forme de microcapsules ou de microparticules lors d'une réticulation par réticulation interfaciale. Ces microcapsules ou microparticules présentent généralement un diamètre se situant dans l'intervalle compris entre 0, 1 μm et 3 mm. La première étape du procédé de l'invention consiste à réaliser préalablement la réticulation des tanins, en l'absence de protéines, et peut être réalisée conformément à l'exemple 1 de FR-A-2 715 582.According to an advantageous embodiment of the invention, the crosslinking of the tannins takes place by interfacial crosslinking, and in the currently preferred case where the tannins are water-soluble, the interfacial crosslinking is carried out on an emulsion in which the dispersed phase is an aqueous phase containing the tannins in solubilized form, by an interfacial crosslinking agent present in a continuous hydrophobic phase. This interfacial crosslinking technique is advantageously that described in document FR-A-2 715 582 which is incorporated here by reference, in particular from page 6, line 30 to page 10, line 22, as well as manufacturing examples 1 to 25. It will be observed in particular that the crosslinking agent comprises a diacid chloride, preferably chosen from the group consisting of an aliphatic or aromatic diacid chloride, such as sebacoyl chloride, succinyl chloride, apipoyl chloride, terephthaloyl chloride, glutaryl chloride. The concentration of diacid chloride will preferably be between 0.2% and 10% by weight of the total weight of the reaction medium. As substances used to constitute the hydrophobic phase, it is possible to use liquid substances well known to those skilled in the art such as those mentioned on page 8, lines 7 to 14, and in particular fatty acid esters such as isopropyl myristate or ethyl oleate, mixtures of fatty acid esters commercially available such as for example the product Dragoxat ®, sold by the company Dragoco, vegetable oils, such as liquid olive, sweet almond oil, peanut oil, mineral oils, such as paraffin oil and any mixture of these liquid and hydrophobic substances. It is understandable that vegetable oils are particularly interesting since they are compatible with a cosmetic or pharmaceutical application. It is also possible to use surfactants to facilitate the preparation of the emulsion as described on page 8, lines 15 to 22 of FR-A-2 715 582 where a person skilled in the art may refer. Thus, the crosslinked tannins can advantageously be in the form of microcapsules or microparticles during crosslinking by interfacial crosslinking. These microcapsules or microparticles generally have a diameter lying in the range between 0.1 μm and 3 mm. The first step of the process of the invention consists in carrying out beforehand the crosslinking of the tannins, in the absence of proteins, and can be carried out in accordance with Example 1 of FR-A-2 715 582.
Lors de la réticulation de tanins constitués par des oligomères procyanidoliques de pépins de raisin, en abrégé OPC PR, on pourra utiliser les conditions de l'exemple 5, qui sont combinés au protocole décrit à l'exemple 1 de FR-A-2 715 582.During the crosslinking of tannins constituted by procyanidolic oligomers of grape seeds, abbreviated OPC PR, the conditions of Example 5 can be used, which are combined with the protocol described in Example 1 of FR-A-2 715 582.
Selon un quatrième aspect, la présente invention couvre encore un procédé de traitement cosmétique de la peau, pour améliorer le lissage de la peau, pour obtenir un effet astringent sur la peau, en particulier un effet raffermissant, caractérisé en ce qu'il comprend l'application sur les zones de la peau concernées d'une quantité efficace de tanins réticulés en combinaison avec des protéines non réticulées avec les taninsAccording to a fourth aspect, the present invention also covers a method of cosmetic treatment of the skin, to improve the smoothing of the skin, to obtain an astringent effect on the skin, in particular a firming effect, characterized in that it comprises the application to the affected areas of the skin of an effective amount of crosslinked tannins in combination with proteins not crosslinked with the tannins
D'autres vanantes de réalisation de ce procédé de traitement cosmétique résultent de la description précédente relativement à l'un ou l'autre des trois premiers aspects, ainsi que des revendications.Other aspects of carrying out this cosmetic treatment process result from the preceding description relating to one or other of the first three aspects, as well as from the claims.
La présente invention va maintenant être décrite en relation avec un exemple actuellement préféré de l'invention donné simplement à titre d'illustration et qui ne saurait donc en aucune façon limiter la portée de l'invention, avec démonstration de l'activité de lissage de la peau, des exemples de formulations cosmétiques ou pharmaceutiques étant ensuite donnés également à titre d'illustration.The present invention will now be described in relation to a currently preferred example of the invention given simply by way of illustration and which therefore cannot in any way limit the scope of the invention, with demonstration of the smoothing activity of the skin, examples of cosmetic or pharmaceutical formulations being then also given by way of illustration.
Exemple 1 de l'inventionExample 1 of the invention
Préparation d'une composition comprenant des tanins réticulés sous forme de proanthocvanidines de pépins de raisin réticulés, combinés avec une protéine issue du blé, disponible dans le commerce sous le nom de Tensine® de la société Silab® FrancePreparation of a composition comprising crosslinked tannins in the form of crosslinked grape seed proanthocvanidines, combined with a protein obtained from wheat, commercially available under the name of Tensine® from the company Silab® France
Les étapes de procédé de préparation de cette composition sont les suivantesThe process steps for preparing this composition are as follows
a) Etape de réticulation des proanthocvanidines (OPC) de pépins de raisin Pour réaliser cette étape, on procède comme décrit à l'exemple 5 de FR-a) Cross-linking step of grape seed proanthocvanidins (OPC) To carry out this step, the procedure is carried out as described in Example 5 of FR-
A-2 715 582.A-2,715,582.
Pour ce faire, on prépare tout d'abord une phase aqueuse en dissolvant 300 mg d'une solution d'oligomères procyanidoliques de pépins de raism, références commerciales OPC PR, commercialisé par la société Sarpap, France, dans 3 ml d'un tampon carbonate PH 11, soit environ une proportion de 10 % en OPC. On procède ensuite à une émulsification en émulsionnant 3 ml de cette solution dans 15 ml de cyclohexane additionné de 5 % d'un agent tensioactif, tel que le Span 85® (tπoléate de sorbitan), par agitation à 3 000 rpm Ensuite, après 5 mm d'agitation, on ajoute à l'émulsion 20 ml d'une solution à 5 % en poids/volume d'agents réticulants constitués par le chlorure de téréphtaloyle (CF) commercialisé par Janssen Chimica, dans un mélange de chloroforme . cyclohexane dans un rapport 1.4 volume/volume et on maintient l'agitation pendant 30 minutesTo do this, an aqueous phase is first prepared by dissolving 300 mg of a solution of procyanidolic oligomers of grape seeds, commercial references OPC PR, marketed by the company Sarpap, France, in 3 ml of a buffer. carbonate PH 11, or approximately 10% OPC. To emulsification is then carried out by emulsifying three ml of this solution in 15 ml of cyclohexane with 5% of a surfactant such as Span ® 85 (sorbitan tπoléate) by stirring at 3000 rpm Then, after 5 mm of stirring, 20 ml of a 5% w / v solution of crosslinking agents consisting of terephthaloyl chloride (CF) sold by Janssen Chimica are added to the emulsion. chloroform. cyclohexane in a 1.4 volume / volume ratio and stirring is continued for 30 minutes
On procède ensuite a une séparation des microcapsules obtenues par centπfugation et lavage par remise en suspension successivement dans le cyclohexane, dans l'alcool à 95 % additionné de 2 % de Tween 20 dans l'alcool à 95 % et finalement dans l'eau distillée L'examen microscope optique montre de belles microcapsules sphéπques, transparentes de diamètres 5-25 μm, à l'état de suspension aqueuse.One then proceeds to a separation of the microcapsules obtained by centπfugation and washing by resuspension successively in cyclohexane, in 95% alcohol added with 2% Tween 20 in 95% alcohol and finally in distilled water The optical microscope examination shows beautiful spherical, transparent microcapsules with diameters 5-25 μm, in the form of an aqueous suspension.
b) Préparation du mélange tanins réticulés-protéines de bléb) Preparation of the crosslinked tannin-wheat protein mixture
Selon une première vaπante de réalisation, on sépare les microcapsules préparées à l'étape a) de la suspension aqueuse les contenant par centπfugation.According to a first variant, the microcapsules prepared in step a) are separated from the aqueous suspension containing them by centπfugation.
On réalise des lavages pour éliminer le milieu reactionnel. Les microcapsules ainsi lavées peuvent être mélangées à une solution aqueuse contenant la protéine de blé.Washings are carried out to eliminate the reaction medium. The microcapsules thus washed can be mixed with an aqueous solution containing wheat protein.
En faisant varier les proportions respectives de microcapsules et de protéines de blé, on obtient diverses compositions comprenant diverses concentrations en tanins réticulés, et en protéines, comme cela est bien compréhensible à l'homme de l'art.By varying the respective proportions of microcapsules and wheat proteins, various compositions are obtained comprising various concentrations of crosslinked tannins, and proteins, as is well understood by those skilled in the art.
Ainsi, diverses compositions ont été préparées et elles sont rapportées au tableau III de résultat de l'exemple 5 donné ci-aprèsThus, various compositions were prepared and they are reported in Table III of the result of Example 5 given below.
Exemple 2 de l'inventionExample 2 of the invention
Test de précipitation de la sérum albumine bovine par des concentrations croissantes de proanthocvanidines (OPC) libres et réticulésBovine serum albumin precipitation test with increasing concentrations of free and crosslinked proanthocvanidins (OPC)
Pour réaliser ce test, on utilise une dose constante de sérum albumine bovine du commerce, mise en contact avec des doses croissantes d'OPC libres ou réticuléesTo carry out this test, a constant dose of commercial bovine serum albumin is used, brought into contact with increasing doses of free or crosslinked OPCs.
Apres 15 minutes d'incubation à température ambiante, on effectue une centπfugation afin d'éliminer la sérum albumine éventuellement précipitée Un dosage de protéines est fait sur le surnageant.After 15 minutes of incubation at room temperature, a centrifugation is carried out in order to eliminate the albumin serum which may be precipitated. A protein assay is made on the supernatant.
Un essai sans OPC détermine la quantité de sérum albumine effectivement présente dans le surnageant et définit aussi le 100 % de sérum albumine non précipitée.A test without OPC determines the quantity of albumin serum actually present in the supernatant and also defines the 100% of non-precipitated albumin serum.
La technique de dosage mise en oeuvre est la méthode au bleu de Coomasie avec une lecture de la densité optique respectivement à une longueur d'onde de 590 nanomètres et une longueur d'onde de 465 nanomètres pour mesurer l'absorbance dénommée respectivement Abs59o à 590 nanomètres et Abs465 à 465 nanomètres. Le rapport Abs5 o/Abs 65 permet de déterminer la concentration protéique comme cela est bien compréhensible à l'homme de l'art.The assay technique used is the Coomasie blue method with a reading of the optical density respectively at a wavelength of 590 nanometers and a wavelength of 465 nanometers to measure the absorbance called respectively Abs 59 o at 590 nanometers and Abs 465 at 465 nanometers. The Abs 5 o / Abs 65 ratio makes it possible to determine the protein concentration as is easily understood by those skilled in the art.
Les valeurs du tableau I ci-dessous sont exprimées en pourcentage de sérum albumine bovine ou BSA non-précipitée.The values in Table I below are expressed as a percentage of non-precipitated bovine serum albumin or BSA.
Tableau I ; mesure de BSA non-précipitée en pourcentage en poidsTable I; non-precipitated BSA measurement as a percentage by weight
Figure imgf000009_0001
Figure imgf000009_0001
On obtient ainsi la courbe de précipitation de la sérum albumine bovine ou BSA représentée à la figure 1 qui représente en abscisse la concentration en tanin de 0 à 1 ng/ml et en ordonnée le % en sérum albumine bovine (BSA) soluble.The precipitation curve for bovine serum albumin or BSA shown in FIG. 1 is thus obtained, which represents the tannin concentration of 0 to 1 ng / ml on the abscissa and the% in soluble bovine serum albumin (BSA) on the ordinate.
La courbe 1 est la courbe témoin sans tanin, la courbe 2 est la courbe obtenue avec des tanins réticulés, ici des OPC réticulés et la courbe 3 est la courbe obtenue avec des tanins libres, ici des OPC libres ou non réticulés.Curve 1 is the control curve without tannin, curve 2 is the curve obtained with crosslinked tannins, here crosslinked OPCs and curve 3 is the curve obtained with free tannins, here free or uncrosslinked OPCs.
On constate à partir du tableau I et de la figure 1 que lorsque les OPC sont réticulés, il n'y a essentiellement pas de précipitation de la protéine, contrairement aux OPC Libres. Exemple 3 de l'inventionIt can be seen from Table I and FIG. 1 that when the OPCs are crosslinked, there is essentially no precipitation of the protein, unlike the Free OPCs. Example 3 of the invention
Test d'interaction entre le collagène de type 1 et les OPC libres ou réticulés L'interaction collagène-tanin due à l'expression de liaisons hydrogènes se traduit par une augmentation du taux de réticulation du collagène et par conséquent de sa viscosité.Interaction test between type 1 collagen and free or crosslinked OPCs The collagen-tannin interaction due to the expression of hydrogen bonds results in an increase in the crosslinking rate of collagen and consequently in its viscosity.
Dans ce test, une concentration constante de collagène de type 1 est mise en présence de concentration croissante d'OPC libre et réticulé. On mesure la viscosité du mélange grâce à un viscosimètre deIn this test, a constant concentration of type 1 collagen is brought into contact with an increasing concentration of free and crosslinked OPC. The viscosity of the mixture is measured using a viscometer of
Ubbelohde, disponible dans le commerce, bien connu à l'homme de l'art, réf. 0,78 IT, à une température de 29°C.Ubbelohde, commercially available, well known to those skilled in the art, ref. 0.78 IT, at a temperature of 29 ° C.
Les résultats de cet essai sont rapportés à la figure 2 qui représente en abscisse la concentration en % en OPC qui varie de 0 à 0,25 %, en fonction de la viscosité relative en ordonnée pour une concentration constante de collagène de type 1 de 0,05 % dans de l'eau à 29°C.The results of this test are reported in FIG. 2 which represents on the abscissa the concentration in% of OPC which varies from 0 to 0.25%, as a function of the relative viscosity on the ordinate for a constant concentration of type 1 collagen of 0 0.05% in water at 29 ° C.
La courbe 1 est obtenue avec la solution de collagène témoin, la courbe 2 est obtenue en ajoutant une concentration croissante en OPC libre et la courbe 3 est obtenue en ajoutant à la solution de collagène une concentration croissante d'OPC réticulés, obtenus selon l'exemple la).Curve 1 is obtained with the control collagen solution, curve 2 is obtained by adding an increasing concentration of free OPC and curve 3 is obtained by adding to the collagen solution an increasing concentration of crosslinked OPCs, obtained according to example).
Ce deuxième test confirme l'absence de phénomène de pontage entre les protéines et les OPC réticulés contrairement au phénomène observé bien connu avec les OPC libres.This second test confirms the absence of a bridging phenomenon between proteins and crosslinked OPCs, unlike the well-known phenomenon observed with free OPCs.
Exemple 4 de l'inventionExample 4 of the invention
Test de cinétique d'hydrolyse par une estérase des OPC réticulésHydrolysis kinetics test with crosslinked OPC esterase
On utilise les microcapsules d'OPC telles qu'obtenues à l'exemple la. Ces microcapsules d'OPC sont formées à la suite de l'établissement de liaisons esters. La membrane qui se forme est donc constituée de flavonoïdes estérifiés. Il est démontré par le présent test que sous l'action d'estérase, il y a libération au cours du temps de monomères procyanidoliques. Le présent test consiste à mettre en présence 286 unités d'estérase, constituées par une estérase E 3019 d'origine du pancréas de porc disponible dans le commerce chez Sigma, avec des OPC réticulés selon l'exemple la, et après centrifugation à différents temps (30 mn ; 1 heure ; 2 heures ; 3 heures ; 4 heures et 6 heures), la composition du surnageant est visualisée par chromatographie HPLC.OPC microcapsules are used as obtained in example la. These OPC microcapsules are formed following the establishment of ester bonds. The membrane that forms is therefore made up of esterified flavonoids. It is demonstrated by the present test that under the action of esterase, there is release over time of procyanidol monomers. The present test consists in bringing together 286 esterase units, constituted by an E 3019 esterase from the porcine pancreas commercially available from Sigma, with crosslinked OPCs according to example la, and after centrifugation at different times. (30 min; 1 hour; 2 hours; 3 hours; 4 hours and 6 hours), the composition of the supernatant is visualized by HPLC chromatography.
L'apparition de monomères dans le surnageant est très nette, ce qui prouve l'action de l'estérase.The appearance of monomers in the supernatant is very clear, which proves the action of esterase.
Les résultats obtenus sont répertoriés au tableau II ci-après :The results obtained are listed in Table II below:
Tableau II : Hydrolyse par une estérase des OPC réticulésTable II: Hydrolysis by an esterase of crosslinked OPCs
Figure imgf000011_0001
Figure imgf000011_0001
On sait que les estérases sont sécrétées à partir des corps d'Ocland dans le stratum granulosum qui vont migrer vers la surface du stratum corneum. La présence des estérases au niveau de la couche superficielle de la peau va permettre une attaque des microcapsules d'OPC réticulés et ainsi libérer les oligomέres procyanidiques doués de propriété tannante et qui vont procéder à une réticulation du collagène présent dans la couche superficielle de la peau et procurer ainsi l'effet lissant de la peau mis en évidence par la présente invention, ce qui est confirmé par les essais de lissage ci-après.It is known that esterases are secreted from Ocland bodies in the stratum granulosum which will migrate to the surface of the stratum corneum. The presence of esterases in the surface layer of the skin will allow an attack on the crosslinked OPC microcapsules and thus release the procyanidic oligomers endowed with tanning properties and which will crosslink the collagen present in the surface layer of the skin. and thus provide the smoothing effect of the skin demonstrated by the present invention, which is confirmed by the smoothing tests below.
Exemple 5 de l'inventionExample 5 of the invention
ESSAIS DE LISSAGE DE LA PEAU Des essais de lissage de la peau ont été réalisés sur un groupe de 32 personnes volontaires.SKIN SMOOTHING TESTS Skin smoothing tests were carried out on a group of 32 volunteers.
Chaque personne a reçu sur des zones de peau différentes de l'un des avant-bras, 4 compositions différentes selon l'invention, telles que préparées à l'exemple 1. Sur une zone de peau de l'autre avant-bras, elles reçoivent une composition témoin constituée uniquement de l'excipient desdites compositions de l'exemple 1.Each person received on different skin areas of one of the forearms, 4 different compositions according to the invention, as prepared in Example 1. On a skin area of the other forearm, they receive a control composition consisting solely of the excipient of said compositions of Example 1.
Une seule application de chaque composition est réalisée. Deux heures après l'application des compositions, une empreinte de peau sur les zones d'application est réalisée, selon une technique bien connue de l'homme de l'art.Only one application of each composition is made. Two hours after the application of the compositions, a skin impression on the application areas is carried out, according to a technique well known to those skilled in the art.
Une étude du micro-relief dépressionnaire des rides de la peau est ensuite réalisée à partir de ces empreintes, au moyen d'un analyseur d'image classique. Les résultats obtenus, représentant la moyenne des observations par rapport aux empreintes témoins, sont rapportés au tableau III ci-après.A study of the micro-relief of wrinkles in the skin is then carried out using these imprints, using a conventional image analyzer. The results obtained, representing the average of the observations relative to the control fingerprints, are reported in Table III below.
Dans ce tableau, l'indication ± signifie un effet non-significatif,In this table, the indication ± signifies a non-significant effect,
L'indication + signifie un effet de lissage de la peau peu significatif,The + indication signifies an insignificant skin smoothing effect,
L'indication ++ signifie un léger lissage de la peau, L'indication +++ signifie une nette diminution des rides et un lissage de la peau assez satisfaisant,The indication ++ means a slight smoothing of the skin, The indication +++ means a marked reduction in wrinkles and a fairly satisfactory smoothing of the skin,
L'indication ++++ signifie une diminution très nette de la profondeur des rides et un lissage de la peau très satisfaisant.The indication ++++ signifies a very marked reduction in the depth of wrinkles and a very satisfactory smoothing of the skin.
Dans le tableau ffl ci-après, les concentrations en protéine (tensine) et en tanins, à savoir en oligomères proanthocyanidoliques de pépins de raisin réticulés (OPCPR réticulés) sont exprimés en pourcentage en poids, par rapport au poids total de la composition finale.In table ffl below, the concentrations of protein (tensin) and of tannins, namely of proanthocyanidolic oligomers of crosslinked grape seeds (crosslinked OPC PR ) are expressed as a percentage by weight, relative to the total weight of the final composition. .
Tableau III Effet des compositions de l'invention sur le lissage de la peauTable III Effect of the compositions of the invention on the smoothing of the skin
Figure imgf000012_0001
Il résulte du tableau m ci-dessus, que la combinaison de tanins réticulés avec au moins une protéine, ici des protéines de blé, procure un résultat significatif sur lissage de la peau, alors qu'en l'absence de tanins réticulés, cet effet n'est que peu significatif, quel que soit la concentration en protéine testée. De même, en l'absence de protéine, les tanins réticulés n'ont présenté qu'un effet modéré sur lissage de la peau. Il y a donc un effet de synergie mis en évidence entre les tanins réticulés et la protéine combinés entre eux, conformément à l'invention.
Figure imgf000012_0001
It follows from Table m above, that the combination of crosslinked tannins with at least one protein, here wheat proteins, gives a significant result on skin smoothness, whereas in the absence of crosslinked tannins, this effect is only of little significance, whatever the protein concentration tested. Likewise, in the absence of protein, the crosslinked tannins showed only a moderate effect on skin smoothness. There is therefore a synergistic effect demonstrated between the crosslinked tannins and the protein combined together, in accordance with the invention.
Exemple 6 de l'inventionExample 6 of the invention
Composition dite "coup d'éclat" pour lisser la peau du visageComposition called "radiance boost" to smooth facial skin
Cette composition est préparée à partir des ingrédients suivants : - microcapsules d'OPC réticulés, selon l'exemple la 1 g,This composition is prepared from the following ingredients: - crosslinked OPC microcapsules, according to example 1 g,
- Carbopol 940® 0.05 g,- Carbopol 940 ® 0.05 g,
- tensine 5g- 5g tensin
-excipient parfumé aqueux avec conservateur qsp 100 g.- aqueous scented excipient with preservative qs 100 g.
Pour préparer cette composition, on solubilise les 5 g de tensine dans environ 40 g d'eau distillée, à froid sous agitation mécanique, puis, on disperse 1 g des microcapsules d'OPC réticulés préparées suivant l'exemple la. Tout en maintenant l'agitation, on complète à 50 g avec un excipient aqueux contenant le parfum et les conservateurs. On ajoute ensuite 50 g d'un gel de Carbopol 940 à 0,1 % neutralisé avec de la soude préparé séparément.To prepare this composition, the 5 g of tensin are dissolved in approximately 40 g of distilled water, cold with mechanical stirring, then 1 g of the crosslinked OPC microcapsules prepared according to Example 1a is dispersed. While maintaining stirring, make up to 50 g with an aqueous excipient containing the perfume and the preservatives. Then added 50 g of a 0.1% Carbopol 940 gel neutralized with sodium hydroxide prepared separately.
On obtient ainsi une composition sous forme d'un gel qui, appliqué sur la peau du visage, produit en quelques minutes un effet tenseur qui lisse la peau en atténuant les rides et les ridules. A composition is thus obtained in the form of a gel which, applied to the skin of the face, produces in a few minutes a tightening effect which smoothes the skin by reducing wrinkles and fine lines.

Claims

REVENDICATIONS
1. Utilisation de tanins réticulés en présence de protéines non- réticulées avec les tanins comme agent cosmétique pour le lissage de la peau et/ou pour l'obtention d'un effet astringent.1. Use of crosslinked tannins in the presence of proteins not crosslinked with the tannins as a cosmetic agent for smoothing the skin and / or for obtaining an astringent effect.
2. Utilisation selon la revendication 1 caractérisée en ce que la protéine est ajoutée à une solution contenant les tanins réticulés préalablement préparés.2. Use according to claim 1 characterized in that the protein is added to a solution containing the crosslinked tannins previously prepared.
3. Utilisation selon l'une des revendications précédentes, caractérisée en ce que les tanins réticulés sont obtenus par réticulation interfaciale, en particulier sous forme de microcapsules ou microparticules et les protéines précitées sont présentes dans une solution, en particulier aqueuse, contenant les tanins préalablement préparés.3. Use according to one of the preceding claims, characterized in that the crosslinked tannins are obtained by interfacial crosslinking, in particular in the form of microcapsules or microparticles and the abovementioned proteins are present in a solution, in particular aqueous, containing the tannins beforehand. prepared.
4. Utilisation selon la revendication 1 à 3, caractérisée en ce que la concentration en tanin est comprise entre 0,001 % et 5 %, de préférence entre4. Use according to claim 1 to 3, characterized in that the tannin concentration is between 0.001% and 5%, preferably between
0,01 % et 5 % et encore mieux entre 0,1 % et 1 %, en poids par rapport au poids total de la composition finale, tandis que la concentration en protéine est comprise entre 0,01 % et 10 %, de préférence entre 0,1 % et 10 %, encore mieux entre 1 % et 5 % en poids par rapport au poids total de la composition finale les contenant. 0.01% and 5% and even better between 0.1% and 1%, by weight relative to the total weight of the final composition, while the protein concentration is between 0.01% and 10%, preferably between 0.1% and 10%, even better between 1% and 5% by weight relative to the total weight of the final composition containing them.
5. Utilisation selon l'une des revendications 1 à 4, caractérisée en ce que le tanin précité est une molécule phénolique hydrosoluble ayant un poids moléculaire compris entre 500 et 3 000 Daltons, en particulier constituée par des oligomères procyanidoliques OPC à l'état pur, ou à l'état de mélange sous forme d'extrait de source naturelle, par exemple des proanthocyanidines de pépins de raisin.5. Use according to one of claims 1 to 4, characterized in that the aforementioned tannin is a water-soluble phenolic molecule having a molecular weight of between 500 and 3,000 Daltons, in particular constituted by procyanidolic oligomers OPC in the pure state , or as a mixture in the form of an extract from a natural source, for example grape seed proanthocyanidins.
6. Utilisation selon l'une des revendications précédentes, caractérisée en ce que la protéine précitée est une protéine compatible avec une application cosmétique ou pharmaceutique, en particulier une protéine d'origine animale humaine ou végétale telle qu'une albumine comme la sérum albumine, l'ovalbumine, l'α-lactalbumine, les globulines, le fibrinogène, la caséine, le collagène, l'atélocollagène, la gélatine, les hydrolysats de gélatine, les peptones, l'hémoglobine, les protéines végétales telles que les protéines de soja, des glytélines sous forme non dégradée ou dégradée, les scléroprotéines solubilisées, des protéines issues du lait sous toutes ses formes, la farine de soja. 6. Use according to one of the preceding claims, characterized in that the aforementioned protein is a protein compatible with a cosmetic or pharmaceutical application, in particular a protein of human or vegetable animal origin such as an albumin such as serum albumin, ovalbumin, α-lactalbumin, globulins, fibrinogen, casein, collagen, atelocollagen, gelatin, gelatin hydrolysates, peptones, hemoglobin, vegetable proteins such as soy proteins , glytelins in non-degraded or degraded form, solubilized scleroproteins, proteins from milk in all its forms, soy flour.
7. Procédé de fabrication d'une composition stable dans le temps contenant des tanins, en particulier des oligomères procyanidoliques ou OPC, en présence d'une protéine, caractérisé en ce qu'on réalise dans une première étape la réticulation des tanins en l'absence de ladite protéine et dans une deuxième étape on mélange les tanins réticulés avec ladite protéine.7. Method of manufacturing a composition stable over time containing tannins, in particular procyanidolic oligomers or OPC, in the presence of a protein, characterized in that one carries out in a first step the crosslinking of tannins in the absence of said protein and in a second step, the crosslinked tannins are mixed with said protein.
8. Procédé selon la revendication 7, caractérisé en ce que la réticulation des tanins a lieu par réticulation interfaciale, en particulier sous forme de microcapsule ou microparticule et les protéines précitées sont présentes dans une solution, en particulier aqueuse, contenant les tanins réticulés préalablement préparés.8. Method according to claim 7, characterized in that the crosslinking of the tannins takes place by interfacial crosslinking, in particular in the form of a microcapsule or microparticle and the abovementioned proteins are present in a solution, in particular aqueous, containing the crosslinked tannins previously prepared. .
9. Procédé de traitement cosmétique de la peau, pour améliorer le lissage de la peau, pour obtenir un effet astringent sur la peau, en particulier un effet raffermissant, caractérisé en ce qu'il comprend l'application sur les zones de la peau concernées d'une quantité efficace de tanins réticulés en présence de protéines non réticulées avec les tanins.9. A method of cosmetic treatment of the skin, to improve the smoothing of the skin, to obtain an astringent effect on the skin, in particular a firming effect, characterized in that it comprises application to the areas of the skin concerned an effective amount of crosslinked tannins in the presence of proteins not crosslinked with the tannins.
10. Procédé selon les revendications 7 à 9, caractérisé en ce que les tanins réticulés sont obtenus par réticulation interfaciale, en particulier sous forme de microcapsules ou microparticules et les protéines précitées sont présentes dans une solution, en particulier aqueuse, contenant les tanins réticulés ayant été séparément préalablement préparés.10. Method according to claims 7 to 9, characterized in that the crosslinked tannins are obtained by interfacial crosslinking, in particular in the form of microcapsules or microparticles and the abovementioned proteins are present in a solution, in particular aqueous, containing the crosslinked tannins having been separately previously prepared.
1 1. Procédé selon l'une des revendications 7 à 10, caractérisé en ce que la concentration en tanin est comprise entre 0,001 % et 5 %, de préférence entre 0,01 % et 5 %, et encore mieux entre 0,1 % et 1 %, en poids par rapport au poids total de la composition, tandis que la concentration en protéine est comprise entre 0,01 % et 10 %, de préférence de 0,1 % et 10 %, encore mieux entre 1 % et 5 % en poids par rapport au poids total de la composition les contenant.1 1. Method according to one of claims 7 to 10, characterized in that the tannin concentration is between 0.001% and 5%, preferably between 0.01% and 5%, and even better between 0.1% and 1%, by weight relative to the total weight of the composition, while the protein concentration is between 0.01% and 10%, preferably 0.1% and 10%, even better between 1% and 5 % by weight relative to the total weight of the composition containing them.
12. Procédé selon l'une des revendications 7 à 11, caractérisé en ce que le tanin précité est une molécule phénolique hydrosoluble ayant un poids moléculaire compris entre 500 et 3 000 Daltons, en particulier constituée par des oligomères procyanidoliques OPC à l'état pur, ou à l'état de mélange sous forme d'extrait de source naturelle, par exemple des proanthocyanidines de pépins de raisin.12. Method according to one of claims 7 to 11, characterized in that the aforementioned tannin is a water-soluble phenolic molecule having a molecular weight of between 500 and 3,000 Daltons, in particular consisting of procyanidolic oligomers OPC in the pure state , or as a mixture in the form of an extract from a natural source, for example grape seed proanthocyanidins.
13. Procédé selon l'une des revendications 7 à 12, caractérisé en ce que la protéine précitée est une protéine compatible avec une application cosmétique ou pharmaceutique, en particulier une protéine d'origine animale, humaine ou végétale telle qu'une albumine comme la sérum albumine, l'ovalbumine, l'α- lactalbumine, les globulines, le fibrinogène, la caséine, le collagène, l'atélocollagène, la gélatine, les hydrolysats de gélatine, les peptones, l'hémoglobine, les protéines végétales telles que les protéines du soja, des glytélines sous forme non dégradée ou dégradée, les scléroprotéines solubilisées, des protéines issues du lait sous toutes ses formes, la farine de soja. 13. Method according to one of claims 7 to 12, characterized in that the aforementioned protein is a protein compatible with a cosmetic application or pharmaceutical, in particular a protein of animal, human or vegetable origin such as an albumin such as serum albumin, ovalbumin, α-lactalbumin, globulins, fibrinogen, casein, collagen, atelocollagen , gelatin, gelatin hydrolysates, peptones, hemoglobin, vegetable proteins such as soy proteins, glytelins in non-degraded or degraded form, solubilized scleroproteins, proteins from milk in all its forms, soy flour.
PCT/FR1998/001364 1997-06-27 1998-06-26 Use of tannins cross-linked in the presence of proteins non-cross-linked with the tannins WO1999000110A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9708100A FR2765106B1 (en) 1997-06-27 1997-06-27 USE OF CROSSLINKED TANNINS IN THE PRESENCE OF NON-CROSSLINKED PROTEINS WITH TANNINS AS COSMETIC AGENTS TO IMPROVE SKIN SMOOTHING AND / OR TO OBTAIN AN ASTRINGENT EFFECT
FR97/08100 1997-06-27

Publications (1)

Publication Number Publication Date
WO1999000110A1 true WO1999000110A1 (en) 1999-01-07

Family

ID=9508546

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR1998/001364 WO1999000110A1 (en) 1997-06-27 1998-06-26 Use of tannins cross-linked in the presence of proteins non-cross-linked with the tannins

Country Status (2)

Country Link
FR (1) FR2765106B1 (en)
WO (1) WO1999000110A1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7897144B2 (en) 2001-02-28 2011-03-01 Johnson & Johnson Comsumer Companies, Inc. Compositions containing legume products
US7985404B1 (en) 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
CN110868873A (en) * 2016-07-13 2020-03-06 尼格食品工程有限公司 Method for crosslinking biopolymers
CN114702692A (en) * 2022-04-01 2022-07-05 中国科学院青岛生物能源与过程研究所 Method for improving stability of protein hydrogel

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2802812B1 (en) * 1999-12-22 2002-08-23 Serobiologiques Lab Sa USE OF RESIDUES FROM THE MANUFACTURE OF WINE FOR THE MANUFACTURE OF COSMETIC AND / OR PHARMACEUTICAL PREPARATIONS.
FR2841134B1 (en) * 2002-06-25 2004-08-20 Vincience COMPOSITION COMPRISING A BIOTRANSFORMATION-MODIFIED CORK EXTRACT

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06336423A (en) * 1993-05-28 1994-12-06 Kose Corp External agent for skin
FR2715582A1 (en) * 1994-02-02 1995-08-04 Centre Nat Rech Scient Microcapsules with a crosslinked flavonoid wall and compositions containing them.
FR2728563A1 (en) * 1994-12-21 1996-06-28 Ovi Sa New ester(s) of aromatic poly:hydroxyl cpds.
FR2731351A1 (en) * 1995-03-10 1996-09-13 Gattefosse Holding Compsn. for smoothing skin
WO1996028008A2 (en) * 1996-03-19 1996-09-19 Guerlain S.A. Novel cosmetic or dermatological compositions for controlling skin ageing
FR2732972A1 (en) * 1995-04-14 1996-10-18 Mathe Lab Prodn. of soluble collagen gel compsns.

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06336423A (en) * 1993-05-28 1994-12-06 Kose Corp External agent for skin
FR2715582A1 (en) * 1994-02-02 1995-08-04 Centre Nat Rech Scient Microcapsules with a crosslinked flavonoid wall and compositions containing them.
WO1995021018A1 (en) * 1994-02-02 1995-08-10 Centre National De La Recherche Scientifique (Cnrs) Microcapsules with walls made of cross-linked plant polyphenols, and compositions containing same
FR2728563A1 (en) * 1994-12-21 1996-06-28 Ovi Sa New ester(s) of aromatic poly:hydroxyl cpds.
FR2731351A1 (en) * 1995-03-10 1996-09-13 Gattefosse Holding Compsn. for smoothing skin
FR2732972A1 (en) * 1995-04-14 1996-10-18 Mathe Lab Prodn. of soluble collagen gel compsns.
WO1996028008A2 (en) * 1996-03-19 1996-09-19 Guerlain S.A. Novel cosmetic or dermatological compositions for controlling skin ageing

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 9508, Derwent World Patents Index; AN 95-057290, XP002054261 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US7985404B1 (en) 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
US7897144B2 (en) 2001-02-28 2011-03-01 Johnson & Johnson Comsumer Companies, Inc. Compositions containing legume products
CN110868873A (en) * 2016-07-13 2020-03-06 尼格食品工程有限公司 Method for crosslinking biopolymers
CN114702692A (en) * 2022-04-01 2022-07-05 中国科学院青岛生物能源与过程研究所 Method for improving stability of protein hydrogel

Also Published As

Publication number Publication date
FR2765106A1 (en) 1998-12-31
FR2765106B1 (en) 2000-12-15

Similar Documents

Publication Publication Date Title
EP0755673B1 (en) Stable composition containing a water-sensitive cosmetic and/or dermatalogic agent
EP0672404B1 (en) Organopolysiloxane containing aqueous make-up gel
EP1082082B1 (en) Composition containing an unstable active agent in an oxidizing medium and uses thereof, especially cosmetic uses
EP0779071B1 (en) Stable w/o/w emulsion containing a water-sensitive cosmetic and/or dermatologic agent
EP0780115B1 (en) Nanoparticles coated with a lamellar phase based on a silicone surfactant and compositions containing them
EP2515840B1 (en) Cosmetic and/or pharmaceutical composition comprising an extract of carob as active agent for activating aquaporin expression
EP0755672B1 (en) Silicon composition containing a water-sensitive agent
EP0912165A1 (en) Cosmetic and/or dermatological composition containing a dispersion of a polymeric system and use of this system as tensor
CA2138876A1 (en) Composition against aging by acting simultaneously on the superficial and deep layers of the skin, and its use
EP0944381A1 (en) Cosmetic and/or dermatological composition containing an aqueous dispersion of a polymeric system and use of this system as tensor
EP0987016A1 (en) Antiwrinkle composition containing a combination of tensor polymers from synthetic and/or natural origin and dendritic polyesters
FR2848847A1 (en) COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION COMPRISING AN AQUEOUS INSOLUBLE ENZYME AND USES THEREOF
EP0759293B1 (en) Stable composition containing an enzyme
EP0628305B1 (en) Stable oil-in-water emulsion type cosmetic or dermatologic composition containing at least one vegetable oil comprising at least 40% triglycerides derived from linolic acid
EP0676195B1 (en) Cosmetic composition for a skin cleansing mask containing graded spheroidal polyamide particles
WO1999000110A1 (en) Use of tannins cross-linked in the presence of proteins non-cross-linked with the tannins
EP0673238B1 (en) Use of a simarouba extract to reduce patchy skin pigmentation
EP0283349B1 (en) Process for obtaining tannic principles of vegetable origin, cosmetologic and pharmaceutical composition containing the tannic principle obtained by the process
EP0904775B2 (en) Emulsion containing ascorbic acid and uses in cosmetic and dermatology
FR2616325A1 (en) COMPOSITION CONTAINING HYDROQUINONE AND KOJIC ACID AND PHARMACEUTICAL COMPOSITION, PARTICULARLY DERMATOLOGICAL, WITH DEPIGMENTING OR ANTI-INFLAMMATORY ACTIVITY, OR COSMETIC COMPRISING KOJIC ACID AND HYDROQUINONE
FR2820973A1 (en) COMPOSITION COMPRISING VITAMIN C PREPARED DURING APPLICATION, USE OF ENZYMES FOR THE FORMATION OF VITAMIN C FOR TOPICAL USE AND COSMETIC PROCESSING METHOD
FR2829025A1 (en) Use of a cosmetic composition comprising an aqueous dispersion of microparticles of a natural polysaccharide gel to correct clinical signs of skin aging associated with cutaneous relaxation
EP0846721B1 (en) Use of melatonin in a composition for stabilising gelable hydrophilic polymers
EP2403474B1 (en) Cosmetic composition for combating skin ageing, formullated and dispensed in the form of a powder turning into a cream upon application
FR2843879A1 (en) New cosmetic compositions with anti-oxidant properties comprises anti-radical agents, useful for skin protection and with anti-ageing effects

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA JP KR US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 1999505341

Format of ref document f/p: F

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA